J. Goldman & Co’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.12M | Buy |
31,250
+23,214
| +289% | +$835K | 0.03% | 241 |
|
2025
Q1 | $317K | Hold |
8,036
| – | – | 0.01% | 273 |
|
2024
Q4 | $242K | Sell |
8,036
-34,751
| -81% | -$1.05M | 0.01% | 289 |
|
2024
Q3 | $1M | Buy |
+42,787
| New | +$1M | 0.03% | 203 |
|
2023
Q3 | – | Sell |
-179,346
| Closed | -$4.45M | – | 352 |
|
2023
Q2 | $4.45M | Buy |
+179,346
| New | +$4.45M | 0.16% | 98 |
|
2021
Q2 | – | Sell |
-41,305
| Closed | -$1.99M | – | 415 |
|
2021
Q1 | $1.99M | Buy |
41,305
+9,591
| +30% | +$462K | 0.06% | 177 |
|
2020
Q4 | $1.65M | Buy |
+31,714
| New | +$1.65M | 0.08% | 162 |
|
2020
Q3 | – | Sell |
-132,414
| Closed | -$2.58M | – | 294 |
|
2020
Q2 | $2.58M | Buy |
132,414
+104,631
| +377% | +$2.04M | 0.16% | 107 |
|
2020
Q1 | $273K | Buy |
+27,783
| New | +$273K | 0.03% | 154 |
|